ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Pharmacoepidemiology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1524068
Drug Stockpiling Behavior and Its Impact on Anxiety among the General Public in the Early Stage after the Lifting of China's Zero-COVID Policy: Results from a Web-based Survey
Provisionally accepted
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: On December 7th, 2022, China lifted most of the restrictions under the so-called zero-COVID policy due to factors like less toxicity of the new variants of the virus, leading to widespread infections throughout China.Objectives: This study aims to assess the stockpiling behavior of COVID-19 medicines by the general population in Zhejiang at the early stage after China's zero-COVID policy cancellation and its impact on people's anxiety.Methods: A cross-sectional, internet-based survey was conducted to collect information on COVID-19 drug purchasing behavior, sociodemographic characteristics, anxiety levels, etc.Chi-square tests and univariate analyses were used to explore the association between COVID-19 medicines purchasing behavior and sociodemographic characteristics. Multivariate analyses were employed to explore the impact of COVID-19 drug purchasing behavior on anxiety status.Results: Among 38,480 participants, stockpiling behavior of COVID-19 medicines was reported by 35.74% of them and was most common among participants from Huzhou area, female, those who aged< 20 years, those with postgraduate education level, health workers. A total of 20,986 (54.54%) participants claimed that they were unable to access any COVID-19 medicines, while 3,742 (9.72%) participants felt it unnecessary to stockpile medicines. The majority of the participants (82.3%) experienced anxiety. Multivariate analyses found that compared to those with severe anxiety, those with moderate anxiety were 1.76 times more likely to have stockpiled COVID-19 medicine (aOR 1.76, 95% CI 1.64-1.89); those with mild anxiety were 2.11 times (aOR 2.11, 95% CI 1.98-2.24) more likely to have stockpiled COVID-19 medicine; those with no anxiety were 2.48 times (aOR 2.48, 95% CI 2.31-2.67) more likely to have stockpiled COVID-19 medicine.Conclusions: At the early stage after China's zero-COVID policy cancellation, drug stockpiling among the public and and the subsequent drug shortage was observed. There exists inequity in distribution between regions and among different groups of people. Many people experienced anxiety, especially those without access to COVID-19 medications. Measures for equitable drug distribution and public education on safe self-medication should be taken for future public health events.
Keywords: COVID-19, Drug stockpiling, Drug shortages, Anxiety, Drug management, China
Received: 07 Nov 2024; Accepted: 23 Apr 2025.
Copyright: © 2025 Huang, Xu, Zhao, Wang, Lv, Wu, Wu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yu Huang, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.